Breast cancer patients to receive a new type of potential treatments.

Breast cancer patients to receive a new type of potential treatments

Breast cancer is the most common cancer in women worldwide. Almost 1.6 million women around the world diagnosed every year. And as an estimate suggests, on average 500,000 women died each year globally. Breast cancer is a group of cancer cells (malignant tumor) that starts in the cells of the breast. These cells can be seen on X-ray or felt a lump. The treatment of breast cancer depends upon the stage. It may consist of chemotherapy, radiation, hormone therapy and surgery. With all these regular treatments, Breast cancer patients to receive a new type of potential treatments near future.

Breast cancer patients to receive a new type of potential treatments

Well, diagnosis at earlier stage lead to better outcomes but the precise detection of it remains more challenging. Generally, Mammograms technique is used, but still, it is not perfect. Scientists now explore whether cutting-edge machine learning technology could help them in detecting and diagnosing breast cancers more effectively than current techniques allow.

Using Artificial Intelligence

Scientists at the Imperial College London working on a new project to investigate how Artificial Intelligence (AI) could enhance breast cancer diagnosis. They believe that it could possibly prompt more exact identification of growths.

As part of this project, machine learning technology from DeepMind Health and the AI health research team at Google will be applied to historic ‘de-identified’ mammograms from around 7,500 women provided by the Cancer Research UK-funded OPTIMAM database at the Royal Surrey County Hospital NHS Foundation Trust.

Through this examination, the group would like to investigate whether it is conceivable to prepare the computer algorithms to break down these pictures, to spot indications of harmful tissue and notify radiologists more precisely than current methods permit. [Reference: Tech Explorist – Improving Breast Cancer treatment using AI]


The National Institute for Health and Care Excellence (NICE) has given constrained endorsement for reasonable NHS patients to get another kind of bosom malignancy treatment spearheaded by clinical researchers at University College London, which will in the end advantage a large number of ladies and is as of now being used in numerous nations all through the world.

The TARGIT IORT ( Targeted Intra-operative RadioTherapy ) technique was conceived, developed and tested since 1998 by Jayant S Vaidya, UCL professor of surgery and oncology, Jeffrey S Tobias, UCL professor of oncology and Michael Baum, UCL emeritus professor of surgery.

The treatment strategy has drawn out time of radiotherapy by rather overseeing a solitary 20-35 minute measurement of radiation straightforwardly into the surgical cavity (tumor bed), under a similar soporific, quickly after the tumor has been expelled.

The TARGIT IORT treatment offers immediate and precise radiotherapy dose in a single session. Whenever patients come round after surgery, the entire of the surgical and radiotherapeutic treatment has been finished in one go. [Reference: Tech Explorist – Targeted Intra-operative Radio Therapy]

Optical Mammography

Scientists at the Optical Society have developed an instrument. It replaces two photo-multiplier tubes (PMT) of existing instruments with an eight-channel probe involving silicon photo-multipliers (SiPMs). It also contains a multi-channel time-to-digital converter. The new instrument is both more powerful and less expensive.

Optical imaging techniques, then again, have pulled in expanding enthusiasm for bosom disease analysis since both unmistakable and infrared light are exceedingly touchy to tissue piece. Tumors are portrayed by a high volume of blood because of the expanded vascularization that happens as tumors develop.

Optical Mammography can be utilized to quantify blood volume, oxygenation, lipid, water and collagen content in a suspicious territory. It is recognized through standard X-beam imaging. Collagen estimations are especially critical since this species is known to be engaged with the beginning and movement of bosom growth. [Reference: Tech Explorist – Treating Breast Cancer using red light]

Machine Learning software

Scientists from Houston Methodist Research Institute have developed a new machine learning software. This new machine learning software accurately diagnoses breast cancer risk 30 times faster than doctors.

This new machine learning software aid doctors to give better treatment. It gives millions of records within a short time. Thus, it allows doctors to discover breast cancer risk more effectively by using patient mammogram. A mammogram is a breast X-ray that aims to spot any potentially cancerous cells before symptoms arise. Meanwhile, it has the potential to reduce unnecessary biopsies. [Reference: Machine Learning software tool]

New test rather searches for circulating tumor DNA

Another examination has discovered a blood test for cancer DNA could anticipate if a woman is reacting to the breast cancer drug palbociclib, months sooner than current tests. Currently, women need to wait for two-three months to find out, using a scan, if palbociclib is working.

This new test rather searches for circulating tumor DNA – fragments of DNA shed by the disease that have entered the bloodstream. The DNA mutations related to the growth can be distinguished in these examples. [Reference: Circulating Tumor DNA test]

New Marker in Blood could Detect Fatal Breast

Scientists at the University College London identified a new marker that could be used to diagnose fatal breast cancer up to one year ahead of current methods. They discovered that progressions distinguished in a piece of DNA which the looks into named EFC#93 could propose early indications of fatal breast cancer. [Reference: New Marker in Blood]

Triple Negative Breast Cancer

Recently team Verrico has donated £9,000 to the European Cancer Stem Cell Research Institute. This aids Professor Matt Smalley’s research group to develop a potential treatment for aggressive breast cancer. According to reports, this funding will help them develop an inhibitor of a molecular switch which the group has found becomes permanently ‘switched on’ in triple negative breast cancer. [Reference: Treatment for Triple Negative Breast Cancer]

Also, Read Causes and risk factors of Neuroendocrine Tumor.

Too many cancers are detected at a late stage when they are more difficult to treat. Hence, early detection is very critical so that more people might survive their disease.

Leave a Comment

Your email address will not be published. Required fields are marked *